223 related articles for article (PubMed ID: 20443227)
1. 3D-QSAR study of benzene sulfonamide analogs as carbonic anhydrase II inhibitors.
Sethi KK; Verma SM; Prasanthi N; Sahoo SK; Parhi RN; Suresh P
Bioorg Med Chem Lett; 2010 May; 20(10):3089-93. PubMed ID: 20443227
[TBL] [Abstract][Full Text] [Related]
2. 3D-QSAR study of sulfonamide inhibitors of human carbonic anhydrase II.
Huang H; Pan X; Tan N; Zeng G; Ji C
Eur J Med Chem; 2007 Mar; 42(3):365-72. PubMed ID: 17118494
[TBL] [Abstract][Full Text] [Related]
3. A systematic quantitative approach to rational drug design and discovery of novel human carbonic anhydrase IX inhibitors.
Sethi KK; Verma SM
J Enzyme Inhib Med Chem; 2014 Aug; 29(4):571-81. PubMed ID: 24090419
[TBL] [Abstract][Full Text] [Related]
4. Docking, CoMFA and CoMSIA studies of a series of sulfonamides derivatives as carbonic anhydrase I inhibitors.
Ghasemi JB; Meftahi N
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):320-7. PubMed ID: 22146078
[TBL] [Abstract][Full Text] [Related]
5. QSAR study on para-substituted aromatic sulfonamides as carbonic anhydrase II inhibitors using topological information indices.
Melagraki G; Afantitis A; Sarimveis H; Igglessi-Markopoulou O; Supuran CT
Bioorg Med Chem; 2006 Feb; 14(4):1108-14. PubMed ID: 16213737
[TBL] [Abstract][Full Text] [Related]
6. 3D QSAR studies, pharmacophore modeling, and virtual screening of diarylpyrazole-benzenesulfonamide derivatives as a template to obtain new inhibitors, using human carbonic anhydrase II as a model protein.
Entezari Heravi Y; Sereshti H; Saboury AA; Ghasemi J; Amirmostofian M; Supuran CT
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):688-700. PubMed ID: 28317396
[TBL] [Abstract][Full Text] [Related]
7. QSAR studies on benzene sulfonamide carbonic anhydrase inhibitors: need of hydrophobic parameter for topological modeling of binding constants of sulfonamides to human CA-II.
Khadikar PV; Sharma V; Karmarkar S; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(4):923-30. PubMed ID: 15686888
[TBL] [Abstract][Full Text] [Related]
8. A selectivity study of benzenesulfonamide derivatives on human carbonic anhydrase II/IX by 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation.
Wang Y; Guo H; Tang G; He Q; Zhang Y; Hu Y; Wang Y; Lin Z
Comput Biol Chem; 2019 Jun; 80():234-243. PubMed ID: 31009872
[TBL] [Abstract][Full Text] [Related]
9. Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: design, synthesis, inhibitory activity and 3D-QSAR analysis.
Wang ZC; Qin YJ; Wang PF; Yang YA; Wen Q; Zhang X; Qiu HY; Duan YT; Wang YT; Sang YL; Zhu HL
Eur J Med Chem; 2013 Aug; 66():1-11. PubMed ID: 23777898
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of novel dioxoacridine sulfonamide derivatives as new carbonic anhydrase inhibitors.
Kaya M; Basar E; Cakir E; Tunca E; Bülbül M
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):509-14. PubMed ID: 21846203
[TBL] [Abstract][Full Text] [Related]
11. A DFT-based quantum theoretic QSAR study of aromatic and heterocyclic sulfonamides as carbonic anhydrase inhibitors against isozyme, CA-II.
Eroglu E; Türkmen H
J Mol Graph Model; 2007 Nov; 26(4):701-8. PubMed ID: 17493855
[TBL] [Abstract][Full Text] [Related]
12. A QSAR study on relationship between structure of sulfonamides and their carbonic anhydrase inhibitory activity using the eigenvalue (EVA) method.
Oltulu O; Yaşar MM; Eroğlu E
Eur J Med Chem; 2009 Sep; 44(9):3439-44. PubMed ID: 19303173
[TBL] [Abstract][Full Text] [Related]
13. Quantum chemical QSAR models to distinguish between inhibitory activities of sulfonamides against human carbonic anhydrases I and II and bovine IV isozymes.
Deeb O; Goodarzi M; Khadikar PV
Chem Biol Drug Des; 2012 Apr; 79(4):514-22. PubMed ID: 22181786
[TBL] [Abstract][Full Text] [Related]
14. 3D-QSAR study of 8-azabicyclo[3.2.1] octane analogs antagonists of cholinergic receptor.
Verma SM; Razdan BK; Sasmal D
Bioorg Med Chem Lett; 2009 Jun; 19(11):3108-12. PubMed ID: 19419864
[TBL] [Abstract][Full Text] [Related]
15. QSAR studies for the inhibition of the transmembrane isozymes XII and XIV of human carbonic anhydrase with a series of sulfonamides.
Tarko L; Supuran CT
Bioorg Med Chem; 2007 Sep; 15(17):5666-71. PubMed ID: 17574422
[TBL] [Abstract][Full Text] [Related]
16. QSAR study on carbonic anhydrase inhibitors: aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties, with topical activity as antiglaucoma agents.
Agrawal VK; Bano S; Supuran CT; Khadikar PV
Eur J Med Chem; 2004 Jul; 39(7):593-600. PubMed ID: 15236839
[TBL] [Abstract][Full Text] [Related]
17. 3D QSAR selectivity analyses of carbonic anhydrase inhibitors: insights for the design of isozyme selective inhibitors.
Weber A; Böhm M; Supuran CT; Scozzafava A; Sotriffer CA; Klebe G
J Chem Inf Model; 2006; 46(6):2737-60. PubMed ID: 17125213
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives.
Innocenti A; Antel J; Wurl M; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Nov; 14(22):5703-7. PubMed ID: 15482952
[TBL] [Abstract][Full Text] [Related]
19. Quantitative structure activity relationship studies of sulfamide derivatives as carbonic anhydrase inhibitor: as antiglaucoma agents.
Kumar S; Singh V; Tiwari M
Med Chem; 2007 Jul; 3(4):379-86. PubMed ID: 17627576
[TBL] [Abstract][Full Text] [Related]
20. Virtual screening-driven identification of human carbonic anhydrase inhibitors incorporating an original, new pharmacophore.
Pala N; Dallocchio R; Dessì A; Brancale A; Carta F; Ihm S; Maresca A; Sechi M; Supuran CT
Bioorg Med Chem Lett; 2011 Apr; 21(8):2515-20. PubMed ID: 21420862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
